Immunovant posts $153M net loss as R&D spending climbs in fiscal Q1

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. NVDA
3. SPY
4. DFTX
5. AZN
6. SATL
7. SRRK
8. LYNX
9. BBNX
10. USO

Go back to Immunovant posts $153M net loss as R&D spending climbs in fiscal Q1
(NASDAQ: IMVT) Delayed: 37.59 +0.23 (0.62%)
Previous Close $37.36    52 Week High $ 
Open $37.25    52 Week Low $ 
Day High $37.77    P/E N/A 
Day Low $37.00    EPS $ 
Volume 85,833       

(NASDAQ: ROIV) Delayed: 40.89 +0.07 (0.17%)
Previous Close $40.82    52 Week High $ 
Open $40.64    52 Week Low $ 
Day High $41.33    P/E N/A 
Day Low $40.44    EPS $ 
Volume 508,740